By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Les Cardoulines HT1, Allée de la Nertière,

Sophia Antipolis   Valbonne   06560   France
Phone: 33-0-497-218-300 Fax: 33-0-493-641-580


Company News
TxCell And Trizell Amend Collaboration Agreement To Accelerate Ovasave Development 4/23/2015 8:50:09 AM
TxCell Strengthens Its Board Of Directors By Appointing Dr. David Solomon To Board And As Chair Of Sub-Committee 4/16/2015 10:04:13 AM
TxCell 2014 Results: Strengthening Of Cash Position And Development Of Astria Product Platform 4/1/2015 9:12:47 AM
Key TxCell Patent To Be Granted In The United States For Its Lead Product Ovasave 3/18/2015 10:31:38 AM
TxCell To Present At ROTH Capital Partners Investor Conference In U.S. 2/26/2015 10:55:24 AM
TxCell Reports Revenues For 2014 And Updates On Upcoming Milestones 2/4/2015 9:42:44 AM
TxCell Announces Its Financial Calendar For 2015 1/30/2015 9:20:17 AM
TxCell Receives EUR 1 Million Milestone Payment Regarding Ovasave® Collaboration Agreement From Trizell 1/29/2015 8:58:10 AM
TxCell Receives EUR 1.7 Million From Bpifrance For Ovasave® Clinical Development In Refractory Crohn’s Disease 1/27/2015 1:31:06 PM
TxCell To Present Its Experience With Cell Therapy At The Cell & Gene Therapy Forum 2015, Washington 1/22/2015 9:51:05 AM